Kringle Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is October - September.

Millions JPY. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 18, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Capitalization	2,918	3,159	5,760	4,318	2,421	3,919
Market Cap Growth	-44.86%	-45.16%	33.41%	78.32%	-38.21%	-
Enterprise Value	2,034	1,527	3,304	1,936	-27	1,690
Last Close Price	397.00	462.00	847.00	798.00	450.00	907.00
PS Ratio	40.17	43.87	72.00	62.58	6.19	13.56
PB Ratio	2.39	2.42	2.73	2.14	0.87	1.56
P/TBV Ratio	2.39	2.42	2.73	2.14	0.87	1.56
P/OCF Ratio	-	-	-	-	161.42	-
EV/Sales Ratio	28.00	21.21	41.30	28.05	-	5.85
Net Debt / Equity Ratio	-0.72	-1.24	-1.10	-1.06	-0.99	-0.85
Asset Turnover	0.03	0.03	0.03	0.02	0.13	0.12
Inventory Turnover	-	-	-	-	0.27	0.39
Quick Ratio	9.28	15.40	18.52	10.61	17.43	17.47
Current Ratio	19.07	18.85	21.52	12.52	19.80	20.74
Return on Equity (ROE)	-58.04%	-53.65%	-36.63%	-35.52%	-12.50%	-12.83%
Return on Assets (ROA)	-24.73%	-23.50%	-19.00%	-19.07%	-9.11%	-8.98%
Return on Capital Employed (ROCE)	-47.50%	-46.10%	-31.10%	-36.90%	-14.00%	-14.30%
Earnings Yield	-31.03%	-29.00%	-13.13%	-19.78%	-13.67%	-7.68%
Buyback Yield / Dilution	-3.93%	-6.92%	-18.72%	-11.00%	-16.91%	-7422.44%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.